Heartflow, Inc. (HTFL) stock

HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30437% above fair value

$48.46−11.46 (-19.13%)

Close on Nov 13, 2026Market cap $4.21BP/E –Yield –

Heartflow price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Heartflow's price to sales ratio was 24.2× on Nov 11, 2026, against 16.6× a year earlier.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	24.2×	+9.1
2025	Dec 31, 2025	15.0×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HTFL.

Revenue growth47.4% · median 21.6%

Gross margin81.8% · median 77.0%

Operating margin-33.1% · median -8.3%

Net margin-33.1% · median -6.9%

Advertisement
300 × 250

See a number that looks wrong?